Your Health, We Care
pemigatinib is an orally active selective inhibitor of fibroblast growth factor receptor (FGFR), with strong inhibitory activity against FGFR1, FGFR2, FGFR3, and FGFR4. Preventing tumor growth and spread by inhibiting FGFR kinase in tumor cells.
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed in many countries and regions around the world, and has achieved significant therapeutic effects and ···【more】
Article source：Lucius LaosRelease date：2024-08-09Recommended：100
Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.How many versions of Pemigatinib are there?From the perspective of drug specifications, Pemigatinib i···【more】
Article source：Lucius LaosRelease date：2024-08-09Recommended：105
Pemigatinibis a targeted drug for the treatment of cholangiocarcinoma and belongs to the FGFR (fibroblast growth factor receptor) inhibitor class.What is Pemigatinib?Pemigatinibis ···【more】
Article source：Lucius LaosRelease date：2024-08-09Recommended：115
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
